Hostname: page-component-74656f9884-skzmx Total loading time: 0 Render date: 2026-11-06T01:20:43.576Z Has data issue: false hasContentIssue false

Synchrotron powder diffraction, X-ray absorption and 1H nuclear magnetic resonance data for hypoxanthine, C5H4N4O

Published online by Cambridge University Press:  13 August 2015

Joel Reid*
Affiliation:
Canadian Light Source, 44 Innovation Boulevard, Saskatoon, SK, Canada S7N 2V3
Toby Bond
Affiliation:
Canadian Light Source, 44 Innovation Boulevard, Saskatoon, SK, Canada S7N 2V3
Shiliang Wang
Affiliation:
Defence Research & Development Canada Suffield, Medicine Hat, AB, Canada T1A 8K6
Jigang Zhou
Affiliation:
Canadian Light Source, 44 Innovation Boulevard, Saskatoon, SK, Canada S7N 2V3
Anguang Hu
Affiliation:
Defence Research & Development Canada Suffield, Medicine Hat, AB, Canada T1A 8K6
*
a) Author to whom correspondence should be addressed. Electronic mails: joel.reid@lightsource.ca, joelwreid@gmail.com

Abstract

Synchrotron powder X-ray diffraction, X-ray absorption spectroscopy (XAS), and proton nuclear magnetic resonance (1H-NMR) data have been used to examine the structure of hypoxanthine, 1,7-dihydro-6H-purin-6-one (C5H4N4O), a purine base that participates in numerous metabolic processes. XAS and 1H-NMR spectroscopy were used to determine that hypoxanthine was present in its keto form (both in solid state and dissolved in an organic solvent). Rigid body refinement was performed with the Rietveld software package GSAS yielding triclinic lattice parameters of a = 7.1179 (2) Å, b = 9.7830 (3) Å, c = 10.4009 (3) Å, α = 58.876 (1)°, β = 67.609 (1)°, and γ = 71.937 (2)° (C5H4N4O, Z = 4, space group P $\bar 1$ ).

Information

Type
New Diffraction Data
Copyright
Copyright © International Centre for Diffraction Data 2015 
Figure 0

Figure 1. (color online) An illustration of the atomic labeling of hypoxanthine (N9H tautomer, left) and the triclinic unit cell of hypoxanthine, with both independent molecules labeled (right).

Figure 1

Table I. The crystal data, data collection, and refinement parameters obtained for the hypoxanthine refinement.

Figure 2

Figure 2. (color online) Structures of the keto and enol N9H tautomers of hypoxanthine. The highlighted protons give rise to expected differences in their respective 1H-NMR spectra.

Figure 3

Figure 3. (color online) The carbon (a) and oxygen (b) K-edge XANES spectra obtained for hypoxanthine. The strong peak at 286.5 eV is because of π* C–N bonding (Samuel et al., 2006).

Figure 4

Figure 4. (color online) A plot of the final Rietveld refinement for hypoxanthine (χ2 = 1.32). The vertical scale has been multiplied by a factor of 10 for 2θ > 14°.

Figure 5

Table II. The refined crystal structure of hypoxanthine (χ2 = 1.32, Rp = 0.0624, Rwp = 0.0831).

Figure 6

Table III. A comparison of the hydrogen bonding values for hypoxanthine from PXRD refinement and the single-crystal structure of Schmalle et al. (1988).

Figure 7

Table IV. The reflection list obtained for hypoxanthine from the Rietveld refinement, including integrated intensities ≥ 0.3%, after summing reflections closer than 0.02° as multiple reflections and using a weighted average reflection position.

Figure 8

Figure 5. (color online) The 1H-NMR spectrum observed for the hypoxanthine sample for chemical shifts between (a) a narrow range of 7.92 and 8.18 ppm and (b) a wide range of 7.5–15 ppm.

Figure 9

Table V. The calculated 1H chemical shifts of the keto N9H tautomer of hypoxanthine in DMSO.

Figure 10

Table VI. The calculated 1H chemical shifts of the keto N7H tautomer of hypoxanthine in DMSO.

Figure 11

Table VII. The calculated 1H chemical shifts of the enol N9H tautomer of hypoxanthine in DMSO.